Discovery and synthesis of rocaglaol derivatives inducing apoptosis in HCT116 cells via suppression of MAPK signaling pathway

Hao-Jie Yang,Ya-Nan Li,Chen Yan,Jue Yang,Yan-Rong Zeng,Ping Yi,Yan-Mei Li,Xiao-Jiang Hao,Chun-Mao Yuan
DOI: https://doi.org/10.1016/j.fitote.2021.104876
IF: 3.204
2021-06-01
Fitoterapia
Abstract:<p>Six rocaglaol derivatives were isolated from <em>Dysoxylum gotadhora</em>, and those compounds showed good cytotoxic activity with IC<sub>50</sub> values ranging from 10 to 350 ng/mL against five different cancer cells. Obviously, further total synthesis of rocaglaol derivatives for medical chemistry study is of great significance. Then, twenty six rocaglaol derivatives including 25 new compounds were designed, synthesized, and evaluated for their cytotoxic activities against three human cancer cell lines: human colon cancer cells (HCT116), colorectal cancer stem cells (P6C), and human red leukocyte leukemia cells (HEL), using MTT assay. Most of derivatives showed good cytotoxic activities, with the lowest IC<sub>50</sub> being 3.2 nM for HEL cells, which was 169 times stronger than that of the positive control (doxorubicin). Further mechanism study indicated that <strong>11k</strong> could significantly suppress MAPK pathway in HCT116 cells, which may responsible for induction of apoptosis and cell cycle arrest.</p>
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?